Examkin

Question

Difficulty: HardInterpreting Imaging Results

A 58-year-old man with a 30-pack-year smoking history undergoes a routine preoperative chest radiograph prior to an elective inguinal hernia repair. The radiograph reveals a newly noted 1.4-cm circumscribed opacity in the periphery of the right upper lobe. He has no cough, hemoptysis, shortness of breath, or weight loss. Physical examination is unremarkable. Vital signs are within normal limits.

Arrange the following diagnostic and management steps in the most appropriate, evidence-based chronological sequence for evaluating this pulmonary finding.

  1. 1Review of the patient's prior chest radiographs or imaging studies
  2. 2High-resolution computed tomography (CT) of the chest without contrast
  3. 3Positron emission tomography (FDG-PET) scan
  4. 4Image-guided percutaneous transthoracic core needle biopsy
  5. 5Video-assisted thoracoscopic surgery (VATS) for tumor resection

Answer

The correct diagnostic sequence for this solitary pulmonary nodule is: 1) Review prior imaging, 2) High-resolution non-contrast chest CT, 3) FDG-PET scan, 4) Image-guided percutaneous biopsy, and 5) VATS resection.
The standard of care for a newly identified solitary pulmonary nodule dictates a rigid step-wise approach. It begins with the least invasive historical comparison (prior imaging) to prove stability. If unavailable or new, anatomical characterization (CT) follows to measure the nodule. Because this nodule is >8 mm (1.4 cm = 14 mm), metabolic risk stratification (PET) is the next step. If hypermetabolic, tissue diagnosis (biopsy) is required, culminating in definitive treatment (resection) if malignant.

Step-by-Step Solution

1
Review prior imaging
Determines the chronological stability of the nodule.
Stability for >24 months essentially confirms a benign etiology, which would halt the algorithm and prevent unnecessary interventions.
2
Perform non-contrast chest CT
Provides high-resolution anatomical detail of the lesion.
CT accurately measures the nodule (the >8 mm threshold is critical for management) and identifies specific benign calcification patterns that plain radiographs cannot reliably show.
3
Obtain FDG-PET scan
Assesses the metabolic activity of the nodule.
Indicated specifically for solid indeterminate nodules >8 mm to stratify the risk of malignancy and guide the decision for tissue sampling versus surveillance.
4
Perform percutaneous image-guided biopsy
Yields a definitive histopathological diagnosis.
Required for highly suspicious peripheral nodules before committing to major oncologic surgery; the peripheral location makes percutaneous biopsy superior to bronchoscopy.
5
Execute VATS resection
Definitively removes the malignant lesion.
This is the standard of care for curative intent in early-stage, localized non-small cell lung cancer confirmed by tissue biopsy.

Key Concept

The step-wise algorithmic evaluation of a solitary pulmonary nodule (SPN) relies first on historical stability, then anatomical characterization via CT, followed by metabolic risk stratification (PET) and tissue diagnosis prior to definitive surgery.
Estimated Time:2m 0s
Rate this question

Topics

Interpreting Imaging Results

More questions from this topic